Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. on PatchTogether Investing’s Substack. In this article, we will summarize the bulls’ thesis on HIMS.
Hims & Hers Health Inc. (HIMS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 0 | $0 | 0% | ||
| 2. | Royce & Associates Chuck Royce | 0 | $0 | 0% | |
| 3. | Magnetar Capital Alec Litowitz And Ross Laser | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | ||
| 5. | Hudson Bay Capital Management Sander Gerber | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.50 | 1,000 | $24,500.00 | 5,000 | 2024-11-14 | Filing | |
| $26.94 | 4,000 | $107,759.60 | 4,000 | 2024-11-12 | Filing | |
| $17.74 | 110,000 | $1,951,763.00 | 110,000 | 2024-05-21 | Filing | |
| $3.66 | 73,700 | $269,742.00 | 125,000 | 2022-06-14 | Filing | |
| $3.66 | 1,300 | $4,751.50 | 51,300 | 2022-06-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $56.00 | 4,150 | $232,400.00 | 278,654 | 2025-09-15 | Filing | |
| $53.81 | 17,810 | $958,381.03 | 160,425 | 2025-09-16 | Filing | |
| $53.03 | 32,190 | $1,706,980.98 | 178,235 | 2025-09-16 | Filing | |
| $53.81 | 17,729 | $954,008.13 | 210,425 | 2025-09-16 | Filing | |
| $53.08 | 23,938 | $1,270,518.93 | 228,154 | 2025-09-16 | Filing |
Institutional Investors' Holdings
News See All
Hims & Hers (HIMS) Steals Spotlight as Court Junks Eli Lilly Lawsuit vs 4 Telehealth Firms
Hims & Hers snapped a two-day losing streak on Wednesday, adding 7.06 percent to finish at $44.46 apiece as investors turned optimistic for telehealth companies after a US judge tossed Eli Lilly’s lawsuit...
Truist Cuts Hims & Hers Health, Inc. (HIMS) Price Target, Cites Mixed Revenue Outlook
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the best Russell 2000 stocks to buy now.
12 Best Russell 2000 Stocks to Buy Now
In its Weekly Market Monitor report for the week ending August 8, 2025, Goldman Sachs noted that U.S. equities had firmly recovered from their April lows.
Hims & Hers (HIMS) Falls as Key Executives Dispose Shares
In separate filings, Chief Legal Officer Soleil Boughton sold 2,572 shares at a price of $51.64 apiece for $132,818, while Chief Medical Officer Patrick Carroll disposed of 60,000 shares for a total of...
Hims & Hers (HIMS) Falls 12.36% on Weaker Revenues
In its updated report, Hims & Hers Health, Inc.
Hims & Hers Health, Inc. (NYSE:HIMS) Q2 2025 Earnings Call Transcript
Operator: Hello, and thank you for standing by. My name is Tiffany, and I will be your conference operator today.
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. on The Musings of Ozz’s substack by Christopher De Ozz. In this article, we will summarize the bulls’ thesis on HIMS.
Hims & Hers Health (HIMS) Expands into Canada with a New Weight Loss Program
Hims & Hers Health, Inc. (NYSE:HIMS) is one of the Stocks With Huge Catalysts on the Horizon. On July 9, Hims & Hers Health, Inc.
Hims & Hers (HIMS) Jumps 14.4% W/W Ahead of Q2 Earnings
Telehealth giant Hims & Hers saw its share prices increase by 14.4 percent week-on-week, from $50.38 to $57.65 on Friday, as investors began repositioning portfolios ahead of its earnings results while...
Hedge Fund Resource Center Billionaire Hedge Funds
